✦ LIBER ✦

A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of avonex in patients with multiple sclerosis

✍ Scribed by J.Theodore Phillips; George Rice; Elliot Frohman; Luc Vande Gaer; Thomas Scott; Judith Haas; Eric Eggenberger; Mark S Freedman; William Stuart; Luis Cunha; Lawrence Jacobs; Joel Oger; Douglas Arnold; T Jock Murray; Mary DiBiase; Vijay Jethwa; Susan Goelz

Book ID: 117321610
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 113 KB
Volume: 26
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(04)90053-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a new formu

Safety and immunogenicity of a new formulation of interferon -1a (Rebif(R) New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results

✍ Giovannoni, G; Barbarash, O; Casset-Semanaz, F; King, J; Metz, L; Pardo, G; Sims 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 223 KB

A multicenter open-label phase I/II stud

A multicenter open-label phase I/II study to assess the safety, tolerability, and efficacy of three dose levels of TuNEX in patients with rheumatoid arthritis

✍ Der-Yuan Chen; Ning-Sheng Lai; Ling-Ying Lu; Hsiu-Cheng Chou; Yi-Hsing Chen; Tsu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 Chinese ⚖ 428 KB

PND2 SAFETY AND IMMUNOGENICITY OF REBIF®

PND2 SAFETY AND IMMUNOGENICITY OF REBIF® NEW FORMULATION (RNF) A NEW SUBCUTANEOUS FORMULATION OF INTERFERON BETA-1A 44 MCG THREE TIMES WEEKLY: 1-YEAR RESULTS OF A PHASE IIIB STUDY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS

✍ J Simsarian; A AL-Sabbagh; R Bennett; B Stubinski; G Pardo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

A Multicenter Open-Label Study to Assess

A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer

✍ Charles Butts; R. Nevin Murray; Colum J. Smith; Peter M. Ellis; Kevin Jasas; And 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 115 KB

A multicenter, randomized, open-label, c

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus

✍ Mary Korytkowski; David Bell; Carol Jacobsen; Rudee Suwannasari; FlexPen® Study 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Effectiveness, pharmacokinetics, and saf

Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: A phase III, open-label, international multicenter study

✍ Michael Marberger; Amir V Kaisary; Neal D. Shore; Gary S. Karlin; Claudio Savuls 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB